Successful heart drug trial prompts Alnylam stock to jump 35 percent ...Middle East

The successful results of a heart drug’s late-stage clinical trial have prompted Alnylam Pharmaceuticals’ stock to jump 35 percent, according to the Wall Street Journal. Read more...

Hence then, the article about successful heart drug trial prompts alnylam stock to jump 35 percent was published today ( Monday 24/06/2024 - 09:00 PM ) and is available on Quartz ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Successful heart drug trial prompts Alnylam stock to jump 35 percent )

Also on site :

• UN report attributes Red Fort blast to Al-Qaeda unit, flags regional threat
• RingConn fait progresser la recherche sur les objets de santé connectés avec une nouvelle étude parue dans Nature Portfolio Journal npj Digital Medicine
• China sees underground market for leaks on Xi's next corruption targets